Environmental exposures, socioeconomics, disparities, and the kidneys

Advances in Chronic Kidney Disease

Volumn 22, Issue 1, 2015, Pages 39-45

  Said, Sarmad ^a   Hernandez, German T ^a  

^a Texas Tech University Health Sciences Center El Paso   (United States)

Author keywords

Cadmium; Chronic kidney disease; Health disparities; Lead; Mercury

Indexed keywords

CADMIUM; HEAVY METAL; LEAD; MERCURY; POLLUTANT;

CENTRAL AMERICA; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; EPIDEMIC; ETHNIC GROUP; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY INJURY; MONOAMERICAN NEPHROPATHY; NEPHROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; PATHOPHYSIOLOGY; REVIEW; SOCIOECONOMICS; ADVERSE EFFECTS; CHEMICALLY INDUCED; CHRONIC KIDNEY FAILURE; ECONOMICS; EPIDEMIOLOGY; ETHNOLOGY; HEALTH DISPARITY; MALE; POLLUTANT; POVERTY; UNITED STATES;

CENTRAL AMERICA; DISEASE PROGRESSION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HEALTH STATUS DISPARITIES; HUMANS; MALE; OCCUPATIONAL EXPOSURE; POVERTY AREAS; RENAL INSUFFICIENCY, CHRONIC; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84920277071     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2014.09.003     Document Type: Review

References (65)

1. Nicholas S.B., Kalantar-Zadeh K., Norris K.C. Racial disparities in kidney disease outcomes. Semin Nephrol 2013, 33(5):409-415.
2. Hossain M.P., Goyder E.C., Rigby J.E., El Nahas M. CKD and poverty: a growing global challenge. Am J Kidney Dis 2009, 53(1):166-174.
3. Jha V., Garcia-Garcia G., Iseki K., et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013, 382(9888):260-272.
4. Merkin S.S., Coresh J., Diez Roux A.V., Taylor H.A., Powe N.R. Area socioeconomic status and progressive CKD: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2005, 46(2):203-213.
5. Merkin S.S., Diez Roux A.V., Coresh J., Fried L.F., Jackson S.A., Powe N.R. Individual and neighborhood socioeconomic status and progressive chronic kidney disease in an elderly population: the Cardiovascular Health Study. Soc Sci Med 2007, 65(4):809-821.
6. Feehally J. Ethnicity and renal disease. Kidney Int 2005, 68(1):414-424.
7. Crews D.C., Pfaff T., Powe N.R. Socioeconomic factors and racial disparities in kidney disease outcomes. Semin Nephrol 2013, 33(5):468-475.
8. Hernandez G.T., Rodriguez R.A. Renal toxicology. Current Occupational and Environmental Medicine 2014, 413-422. McGraw Hill, New York, NY. 5th ed. J. LaDou, R. Harrison (Eds.).
9. Ball S., Lloyd J., Cairns T., et al. Why is there so much end-stage renal failure of undetermined cause in UK Indo-Asians?. QJM 2001, 94(4):187-193.
10. Lightstone L., Rees A.J., Tomson C., Walls J., Winearls C.G., Feehally J. High incidence of end-stage renal disease in Indo-Asians in the UK. QJM 1995, 88(3):191-195.
11. Wedeen R.P. Occupational and environmental renal disease. Semin Nephrol 1997, 17(1):46-53.
12. Navas-Acien A., Tellez-Plaza M., Guallar E., et al. Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol 2009, 170(9):1156-1164.
13. Muntner P., Menke A., DeSalvo K.B., Rabito F.A., Batuman V. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med 2005, 165(18):2155-2161.
14. Lin Y.S., Ginsberg G., Lin J.W., Sonawane B. Mercury exposure and omega-3 fatty acid intake in relation to renal function in the US population. Int J Hyg Environ Health 2014, 217(4-5):465-472.
15. Lin J.L., Lin-Tan D.T., Hsu K.H., Yu C.C. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med 2003, 348(4):277-286.
16. Yu C.C., Lin J.L., Lin-Tan D.T. Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol 2004, 15(4):1016-1022.
17. Chen K.H., Lin J.L., Lin-Tan D.T., et al. Effect of chelation therapy on progressive diabetic nephropathy in patients with type 2 diabetes and high-normal body lead burdens. Am J Kidney Dis 2012, 60(4):530-538.
18. Tyrrell J., Melzer D., Henley W., Galloway T.S., Osborne N.J. Associations between socioeconomic status and environmental toxicant concentrations in adults in the USA: NHANES 2001-2010. Environ Int 2013, 59:328-335.
19. Brown P. Race, class, and environmental health: a review and systematization of the literature. Environ Res 1995, 69(1):15-30.
20. Hightower J.M., O'Hare A., Hernandez G.T. Blood mercury reporting in NHANES: identifying Asian, Pacific Islander, Native American, and multiracial groups. Environ Health Perspect 2006, 114(2):173-175.
21. Blood lead levels in children aged 1-5 years-United States, 1999-2010. MMWR Morb Mortal Wkly Rep 2013, 62(13):245-248. Centers for Disease Control and Prevention.
22. Rabinowitz M.B., Wetherill G.W., Kopple J.D. Kinetic analysis of lead metabolism in healthy humans. J Clin Invest 1976, 58(2):260-270.
23. Rabinowitz M.B. Toxicokinetics of bone lead. Environ Health Perspect 1991, 91:33-37.
24. Sabath E., Robles-Osorio M.L. Renal health and the environment: heavy metal nephrotoxicity. Nefrologia 2012, 32(3):279-286.
25. Barbosa F., Tanus-Santos J.E., Gerlach R.F., Parsons P.J. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect 2005, 113(12):1669-1674.
26. Wedeen R.P. Use of the CaNa2 EDTA Pb-mobilization test to detect occult lead nephropathy. Uremia Invest 1985, 9(2):127-130.
27. Pirkle J.L., Brody D.J., Gunter E.W., et al. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). JAMA 1994, 272(4):284-291.
28. Kaiser R., Henderson A.K., Daley W.R., et al. Blood lead levels of primary school children in Dhaka, Bangladesh. Environ Health Perspect 2001, 109(6):563-566.
29. Morse D.L., Landrigan P.J., Rosenblum B.F., Hubert J.S., Housworth J. El Paso revisited. Epidemiologic follow-up of an environmental lead problem. JAMA 1979, 242(8):739-741.
30. Garcia-Vargas G.G., Rothenberg S.J., Silbergeld E.K., et al. Spatial clustering of toxic trace elements in adolescents around the Torreon, Mexico lead-zinc smelter. J Expo Sci Environ Epidemiol 2014, 24(6):634-642.
31. Ortega F., Counter S.A., Buchanan L.H., Parra A.M., Collaguaso M.A., Jacobs A.B. Tracking blood lead and zinc protoporphyrin levels in Andean adults working in a lead contaminated environment. J Toxicol Environ Health A 2013, 76(19):1111-1120.
32. Haefliger P., Mathieu-Nolf M., Lociciro S., et al. Mass lead intoxication from informal used lead-acid battery recycling in Dakar, Senegal. Environ Health Perspect 2009, 117(10):1535-1540.
33. Moszynski P. Lead poisoning in Nigeria causes "unprecedented" emergency. BMJ 2010, 341:c4031.
34. Gottesfeld P., Pokhrel A.K. Review: lead exposure in battery manufacturing and recycling in developing countries and among children in nearby communities. J Occup Environ Hyg 2011, 8(9):520-532.
35. McKelvey W., Gwynn R.C., Jeffery N., et al. A biomonitoring study of lead, cadmium, and mercury in the blood of New York City adults. Environ Health Perspect 2007, 115(10):1435-1441.
36. Prakash S., Hernandez G.T., Dujaili I., Bhalla V. Lead poisoning from an ayurvedic herbal medicine in a patient with chronic kidney disease. Nat Rev Nephrol 2009, 5(5):297-300.
37. Lead poisoning associated with use of traditional ethnic remedies-California, 1991-1992. MMWR Morb Mortal Wkly Rep 1993, 42(27):521-524. Centers for Disease Control and Prevention.
38. Childhood lead poisoning associated with tamarind candy and folk remedies-California, 1999-2000. MMWR Morb Mortal Wkly Rep 2002, 51(31):684-686. Centers for Disease Control and Prevention.
39. Infant lead poisoning associated with use of tiro, an eye cosmetic from Nigeria-Boston, Massachusetts, 2011. MMWR Morb Mortal Wkly Rep 2012, 61(30):574-576. Centers for Disease Control and Prevention.
40. Inglis J.A., Henderson D.A., Emmerson B.T. The pathology and pathogenesis of chronic lead nephropathy occurring in Queensland. J Pathol 1978, 124(2):65-76.
41. Wedeen R.P., Malik D.K., Batuman V. Detection and treatment of occupational lead nephropathy. Arch Intern Med 1979, 139(1):53-57.
42. Tsaih S.W., Korrick S., Schwartz J., et al. Lead, diabetes, hypertension, and renal function: the normative aging study. Environ Health Perspect 2004, 112(11):1178-1182.
43. Lin J.L., Lin-Tan D.T., Li Y.J., Chen K.H., Huang Y.L. Low-level environmental exposure to lead and progressive chronic kidney diseases. Am J Med 2006, 119(8):707.e1-707.e9.
44. Elinder C.G., Jäup L. Cadmium exposure and health risks: recent findings. Ambio 1996, 25(5):370-373.
45. Prozialeck W.C., Edwards J.R. Early biomarkers of cadmium exposure and nephrotoxicity. Biometals 2010, 23(5):793-809.
46. Hwangbo Y., Weaver V.M., Tellez-Plaza M., Guallar E., Lee B.K., Navas-Acien A. Blood cadmium and estimated glomerular filtration rate in Korean adults. Environ Health Perspect 2011, 119(12):1800-1805.
47. Hellstrom L., Elinder C.G., Dahlberg B., et al. Cadmium exposure and end-stage renal disease. Am J Kidney Dis 2001, 38(5):1001-1008.
48. Becker K., Kaus S., Krause C., et al. German Environmental Survey 1998 (GerES III): environmental pollutants in blood of the German population. Int J Hyg Environ Health 2002, 205(4):297-308.
49. Mannino D.M., Holguin F., Greves H.M., Savage-Brown A., Stock A.L., Jones R.L. Urinary cadmium levels predict lower lung function in current and former smokers: data from the Third National Health and Nutrition Examination Survey. Thorax 2004, 59(3):194-198.
50. Fourth National Report on Human Exposure to Environmental Chemicals 1999, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services Centers for Disease Control and Prevention, Atlanta, GA.
51. Mijal R.S., Holzman C.B. Blood cadmium levels in women of childbearing age vary by race/ethnicity. Environ Res 2010, 110(5):505-512.
52. Park J.D., Zheng W. Human exposure and health effects of inorganic and elemental mercury. J Prev Med Public Health 2012, 45(6):344-352.
53. Hightower J.M., Moore D. Mercury levels in high-end consumers of fish. Environ Health Perspect 2003, 111(4):604-608.
54. Mahaffey K.R., Clickner R.P., Jeffries R.A. Adult women's blood mercury concentrations vary regionally in the United States: association with patterns of fish consumption (NHANES 1999-2004). Environ Health Perspect 2009, 117(1):47-53.
55. Li S.J., Zhang S.H., Chen H.P., et al. Mercury-induced membranous nephropathy: clinical and pathological features. Clin J Am Soc Nephrol 2010, 5(3):439-444.
56. Tang H.L., Chu K.H., Mak Y.F., et al. Minimal change disease following exposure to mercury-containing skin lightening cream. Hong Kong Med J 2006, 12(4):316-318.
57. Sommar J.N., Svensson M.K., Bjor B.M., et al. End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden. Environ Health 2013, 12:9.
58. Brooks D.R., Ramirez-Rubio O., Amador J.J. CKD in Central America: a hot issue. Am J Kidney Dis 2012, 59(4):481-484.
59. Peraza S., Wesseling C., Aragon A., et al. Decreased kidney function among agricultural workers in El Salvador. Am J Kidney Dis 2012, 59(4):531-540.
60. Torres C., Aragon A., Gonzalez M., et al. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis 2010, 55(3):485-496.
61. Wijkstrom J., Leiva R., Elinder C.G., et al. Clinical and pathological characterization of Mesoamerican nephropathy: a new kidney disease in Central America. Am J Kidney Dis 2013, 62(5):908-918.
62. Weiner D.E., McClean M.D., Kaufman J.S., Brooks D.R. The Central American epidemic of CKD. Clin J Am Soc Nephrol 2013, 8(3):504-511.
63. Wesseling C., Crowe J., Hogstedt C., et al. Resolving the enigma of the Mesoamerican nephropathy: a research workshop summary. Am J Kidney Dis 2014, 63(3):396-404.
64. Roncal Jimenez C.A., Ishimoto T., Lanaspa M.A., et al. Fructokinase activity mediates dehydration-induced renal injury. Kidney Int 2014, 86(2):294-302.
65. Krinsky L.M., Levine W.J. An island of widows: the human face of Mesoamerican endemic nephropathy. Kidney Int 2014, 86(2):221-223.